PETKANAS DEAN (Chief Executive Officer) sold 1.3% of their position (320K shares) of NEUROPATHIX, INC. on the open market
Open‑market sale worth $6.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 6/13/2022ACC: 0001607062-22-000413
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
-720K
Net shares
Net seller
$13.2K
Total sold
4
Open market trades
0B · 4S
6
Total transactions
720K disposed
Non-Derivative Transactions6
Common Stock
Direct
Shares
−10K
Price / share
$0.03
Trade value
$250.00
% of position
0.0%
6/6/2022
23.88M→23.87M
Common Stock
Direct
Shares
−50K
Price / share
$0.02
Trade value
$1K
% of position
0.2%
6/7/2022
23.87M→23.82M
Common Stock
Direct
Shares
−21.84K
Price / share
$0.02
Trade value
$458.56
% of position
0.1%
6/8/2022
23.82M→23.80M
Common Stock
Direct
Shares
−238.16K
Price / share
$0.02
Trade value
$5K
% of position
1.0%
6/9/2022
23.80M→23.56M
Common Stock
Direct
Shares
−300K
Price / share
$0.02
Trade value
$4.83K
% of position
1.3%
6/13/2022
23.56M→23.26M
Common Stock
Direct
Shares
−100K
Price / share
$0.02
Trade value
$1.61K
% of position
0.4%
6/13/2022
23.25M→23.15M
Total
Net shares
−720K
Net value
-$13.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2022 | S · Sale | −10K | $0.03 | $250.00 | 0.0% | 23.88M | 23.87M |
| Common Stock Direct | 6/7/2022 | S · Sale | −50K | $0.02 | $1K | 0.2% | 23.87M | 23.82M |
| Common Stock Direct | 6/8/2022 | S · Sale | −21.84K | $0.02 | $458.56 | 0.1% | 23.82M | 23.80M |
| Common Stock Direct | 6/9/2022 | S · Sale | −238.16K | $0.02 | $5K | 1.0% | 23.80M | 23.56M |
| Common Stock Direct | 6/13/2022 | G · Gift | −300K | $0.02 | $4.83K | 1.3% | 23.56M | 23.26M |
| Common Stock Direct | 6/13/2022 | G · Gift | −100K | $0.02 | $1.61K | 0.4% | 23.25M | 23.15M |
| Total | −720K | -$13.15K | ||||||
Derivative Transactions0
No derivative transactions reported